09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3510 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
(51) (97) (54)<br />
A61K 38/06 (2006.01) EP 2086994 * INHIBITORS OF HEPATITIS C VIRUS<br />
A61K 38/07 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS<br />
A61K 38/12 (2006.01) EP 2<strong>09</strong>9468 * METHODS OF USE OF TRK RECEPTOR MODULATORS<br />
A61K 38/17 (2006.01) EP 2089046 * ANTIDIABETOGENIC CALCIUM-PEPTIDE COMPOSITION<br />
A61K 38/17 (2006.01) EP 2<strong>09</strong>1555 * USE OF IL-27 AGONISTS TO REDUCE IMMUNE MEDIATED ABORTION<br />
A61K 38/17 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />
ACTIVITY<br />
A61K 38/17 (2006.01) EP 2<strong>09</strong>5127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3,<br />
AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2<br />
A61K 38/18 (2006.01) EP 2<strong>09</strong>9472 * INTRA-VASCULAR KIDNEY GENE THERAPY WITH PLASMID ENCODING BMP-7<br />
A61K 38/19 (2006.01) EP 2<strong>09</strong>4290 * ENHANCING PULMONARY HOST DEFENSE VIA ADMINISTRATION OF GRANULOCYTE-<br />
MACROPHAGE COLONY STIMULATING FACTOR<br />
A61K 38/20 (2006.01) EP 2<strong>09</strong>1555 * USE OF IL-27 AGONISTS TO REDUCE IMMUNE MEDIATED ABORTION<br />
A61K 38/21 (2006.01) EP 2<strong>09</strong>7068 * FORMULATIONS OF PEG-INTERFERON ALPHA CONJUGATES<br />
A61K 38/22 (2006.01) EP 2086569 * USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE<br />
PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES<br />
A61K 38/26 (2006.01) EP 1985304 Novel compounds and their effects on feeding behaviour<br />
A61K 38/27 (2006.01) EP 2<strong>09</strong>9474 * USE OF GHRELIN TO REVERSE HAIR LOSS<br />
A61K 38/47 (2006.01) EP 1886690 Pharmaceutical composition for the treatment of food intolerance<br />
A61K 38/48 (2006.01) EP 2086571 * TISSUE PLASMINOGEN ACTIVATOR VARIANT USES<br />
A61K 39/00 (2006.01) EP 2004220 * METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY<br />
A61K 39/00 (2006.01) EP 2089432 * ANTI-GLYCOPROTEIN VI SCFV FRAGMENT FOR TREATMENT OF THROMBOSIS<br />
A61K 39/00 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
A61K 39/02 (2006.01) EP 2<strong>09</strong>9479 * SALMONELLA VACCINE IN POULTRY<br />
A61K 39/02 (2006.01) EP 2<strong>09</strong>9480 * MICROORGANISMS OF FRACTIONS THEREOF CAPABLE OF ACTIVATING CELLULAR<br />
IMMUNITY AGAINST CARBOHYDRATES<br />
A61K 39/08 (2006.01) EP 2004220 * METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY<br />
A61K 39/08 (2006.01) EP 2086580 * PRIME BOOST CANINE LEISHMANIA VACCINE<br />
A61K 39/<strong>09</strong> (2006.01) EP 2<strong>09</strong>7100 * PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS<br />
AND USES RELATING THERETO<br />
A61K 39/13 (2006.01) EP 2<strong>09</strong>7102 * COMBINATION VACCINE HAVING REDUCED POLIO VIRUS ANTIGEN QUANTITIES<br />
A61K 39/145 (2006.01) EP 2086582 * VACCINE COMPRISING AN OIL IN WATER EMULSION ADJUVANT<br />
A61K 39/145 (2006.01) EP 2<strong>09</strong>1561 * METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE<br />
A61K 39/285 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />
METHODS<br />
A61K 39/295 (2006.01) EP 2086582 * VACCINE COMPRISING AN OIL IN WATER EMULSION ADJUVANT<br />
A61K 39/385 (2006.01) EP 2<strong>09</strong>2067 * ANTIGENS AND PROTEIN TOXINS, PROCESS OF MANUFACTURING AND USES<br />
THEREOF<br />
MICROORGANISMS AS CARRIERS OF NUCLEOTIDE SEQUENCES CODING FOR<br />
A61K 39/39 (2006.01) EP 2086582 * VACCINE COMPRISING AN OIL IN WATER EMULSION ADJUVANT<br />
A61K 39/395 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
A61K 39/395 (2006.01) EP 2087007 * AGONIST TRKB ANTIBODIES AND USES THEREOF<br />
A61K 39/395 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 39/395 (2006.01) EP 2089059 * METHOD FOR TREATING AGE-RELATED MACULAR DEGENERATION<br />
A61K 39/395 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>1563 * NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NGR)<br />
AND USES THEREOF<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>4247 * STABLE POLYPEPTIDE FORMULATIONS<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>4729 * ABETA ANTIBODY PARENTERAL FORMULATION<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>7104 * NEW A-BETA CONFORMER SELECTIVE ANTI-A-BETA GLOBULOMER MONOCLONAL<br />
ANTIBODIES<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>7450 * ANTIBODY-BASED DIAGNOSTICS AND THERAPEUTICS<br />
A61K 39/395 (2006.01) EP 2<strong>09</strong>9827 * ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND<br />
TREATMENT OF NOTCH3-RELATED DISEASES<br />
A61K 39/40 (2006.01) EP 2004220 * METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY<br />
A61K 45/00 (2006.01) EP 2004220 * METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY<br />
A61K 45/06 (2006.01) EP 2086535 * ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE TREATMENT OF SYSTEMIC<br />
DISEASES IN CATS<br />
A61K 45/06 (2006.01) EP 2086644 * COMBINATION OF AN INHIBITOR OF DNA POLYMERASE-ALPHA AND AN INHIBITOR OF A<br />
CHECKPOINT KINASE FOR PROLIFERATIVE DISORDERS<br />
A61K 45/06 (2006.01) EP 2089046 * ANTIDIABETOGENIC CALCIUM-PEPTIDE COMPOSITION<br />
A61K 45/06 (2006.01) EP 2<strong>09</strong>4259 * RENIN INHIBITORS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION IN<br />
OBESE PATIENTS<br />
ISSN 1331-2030
Change language